Search Results - "Lichtenberger, C."

Refine Results
  1. 1

    The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease by Eser, A., Papay, P., Primas, C., Pernicka, E., Harrer, M., Dejaco, C., Novacek, G., Lichtenberger, C., Angelberger, S., Kazemi, L., Mikulits, A., Vogelsang, H., Reinisch, W.

    Published in Alimentary pharmacology & therapeutics (01-01-2012)
    “…Aliment Pharmacol Ther 2012; 35: 292–299 Summary Background  Antibodies to Saccharomyces cerevisiae (ASCA) are highly prevalent in sera of patients with…”
    Get full text
    Journal Article
  2. 2

    An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgia by Reinisch, W., Miehsler, W., Dejaco, C., Harrer, M., Waldhoer, T., Lichtenberger, C., Vogelsang, H.

    Published in Alimentary pharmacology & therapeutics (01-06-2003)
    “…Summary Background: Conventional non‐steroidal anti‐inflammatory drugs have been associated with an increased risk of exacerbation of inflammatory bowel…”
    Get full text
    Journal Article
  3. 3

    Anti-Gal Titers in Healthy Adults and Inflammatory Bowel Disease Patients by Mangold, A, Lebherz, D, Papay, P, Liepert, J, Hlavin, G, Lichtenberger, C, Adami, A, Zimmermann, M, Klaus, D, Reinisch, W, Ankersmit, H.J

    Published in Transplantation proceedings (01-12-2011)
    “…Abstract Introduction ALPHA-GAL is a glycoconjugate present on cell membranes of mammals and bacteria but not humans who display anti-Gal antibodies (AB) in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Donor dependent, interferon‐γ induced HLA‐DR expression on human neutrophils in vivo by REINISCH, W., LICHTENBERGER, C., STEGER, G., TILLINGER, W., SCHEINER, O., GANGL, A., MAURER, D., WILLHEIM, M.

    Published in Clinical and experimental immunology (01-09-2003)
    “…SUMMARY Neutrophils are effector cells of innate immune responses. Stimulated by interferon‐γ (IFN‐γ) to express HLA‐DR, neutrophils acquire accessory cell…”
    Get full text
    Journal Article
  6. 6

    Tissue-dependent factors affect gene delivery to tumors in vivo by SMREKAR, B, WIGHTMAN, L, WOLSCHEK, M. F, LICHTENBERGER, C, RUZICKA, R, OGRIS, M, RÖDL, W, KURSA, M, WAGNER, E, KIRCHEIS, R

    Published in Gene therapy (01-07-2003)
    “…Systemic application of surface-shielded transferrin-polyethylenimine/DNA complexes leads to predominant DNA uptake and gene expression in Neuro2a tumors in…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease by Tillinger, W, Gasche, C, Reinisch, W, Lichtenberger, C, Bakos, S, Dejaco, C, Moser, G, Vogelsang, H, Gangl, A, Lochs, H

    Published in The American journal of gastroenterology (01-10-1998)
    “…Budesonide, although only topically active, is effective in the treatment of Crohn's disease. This study was performed to compare the clinical efficacies of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies by PANKUCH, G. A, LICHTENBERGER, C, JACOBS, M. R, APPELBAUM, P. C

    Published in Antimicrobial Agents and Chemotherapy (01-07-1996)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  13. 13

    In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel disease by Dejaco, C, Reinisch, W, Lichtenberger, C, Waldhoer, T, Kuhn, I, Tilg, H, Gasche, C

    Published in Journal of investigative medicine (01-11-2000)
    “…Interleukin-10 (IL-10) exhibits potent anti-inflammatory and immunosuppressive activities in vitro. Recent data indicate that treatment with recombinant human…”
    Get full text
    Journal Article
  14. 14

    Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest by Lederer, Wolfgang, Lichtenberger, Christa, Pechlaner, Christoph, Kroesen, Gunnar, Baubin, Michael

    Published in Resuscitation (01-07-2001)
    “…Background: Thrombolytic therapy during cardiopulmonary resuscitation (CPR) is a controversial issue in emergency medicine practice. This study was conducted…”
    Get full text
    Journal Article
  15. 15

    Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice by Wolschek, Markus F., Thallinger, Christiane, Kursa, Malgorzata, Rössler, Vanessa, Allen, Matthew, Lichtenberger, Cornelia, Kircheis, Ralf, Lucas, Trevor, Willheim, Martin, Reinisch, Walter, Gangl, Alfred, Wagner, Ernst, Jansen, Burkhard

    Published in Hepatology (Baltimore, Md.) (01-11-2002)
    “…Systemic tumor-targeted gene delivery is attracting increasing attention as a promising alternative to conventional therapeutical strategies. To be considered…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest by Lederer, Wolfgang, Lichtenberger, Christa, Pechlaner, Christoph, Kinzl, Johann, Kroesen, Gunnar, Baubin, Michael

    Published in Resuscitation (01-05-2004)
    “…Objective: The long-term outcome in patients who received recombinant tissue plasminogen activator during cardiopulmonary resuscitation (CPR) in…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20